Oncology
Senior Medical Oncologist, Hemato-Oncologist & Bone Marrow Transplant Specialist32 Years of Experience in Medical Oncology, Hemato-Oncology and Bone Marrow Transplantation
HCG Cancer Hospital
Bangalore
Dr. Radheshyam Naik is a senior Medical Oncologist, Hemato-Oncologist and Bone Marrow Transplant specialist in Bengaluru with 32 years of experience in the treatment of solid tumors, blood cancers and complex hematological disorders.
His major areas of expertise include leukemia, lymphoma, multiple myeloma, kidney cancer, prostate cancer, lung cancer, bone cancer, colorectal cancer and genitourinary malignancies. He also has extensive experience in systemic treatments such as chemotherapy, targeted therapy and stem cell-based treatment approaches.
Dr. Radheshyam Naik has a special interest in bone marrow transplantation and stem cell therapy, including allogeneic and haploidentical transplantation. He is credited by HCG with performing the first bone marrow transplant in Karnataka and the first intra-arterial chemotherapy using a port.
He completed MBBS, MD in General Medicine and DM in Medical Oncology and subsequently received advanced oncology and transplant training at international institutions in the United States, United Kingdom, Australia and Israel.
Dr. Radheshyam Naik is currently associated with HCG Cancer Centre in Bengaluru and also serves in a leadership role at Sammprada Hospital, where he is involved in medical oncology, hematology and bone marrow transplant care.
Chemotherapy uses anticancer medicines to destroy or control cancer cells and may be used alone or in combination with other treatments depending on cancer type and stage.
Targeted therapy uses medicines designed to act on specific molecular or genetic features of cancer cells and is selected based on tumor characteristics.
Immunotherapy helps the immune system recognise and attack cancer cells and may be used for selected solid tumors and blood cancers.
Leukemia treatment is planned according to leukemia subtype, genetic risk, age, overall health and response to initial therapy.
Lymphoma treatment depends on lymphoma type, stage and biological features and may include systemic therapy, targeted treatment or stem cell transplantation.
Multiple myeloma treatment may involve chemotherapy, targeted medicines, immunomodulatory treatment and autologous stem cell transplantation in suitable patients.
Lung cancer treatment may include chemotherapy, targeted therapy, immunotherapy or combined multidisciplinary treatment according to tumor type and molecular profile.
Medical treatment for prostate cancer may include hormonal therapy, systemic anticancer medicines and targeted approaches depending on disease stage and biology.
Advanced kidney cancer may be managed using targeted therapies and immunotherapy according to tumor characteristics and disease extent.
Systemic colorectal cancer treatment may include chemotherapy and targeted medicines based on stage, molecular findings and multidisciplinary planning.
Autologous transplantation uses the patient's own collected stem cells and may be used in selected blood cancers such as lymphoma and multiple myeloma.
Allogeneic bone marrow transplantation uses healthy donor stem cells and may be considered for selected leukemias and other hematological disorders.
Haploidentical transplantation uses a partially matched family donor and can expand transplant options when a fully matched donor is unavailable.
Stem cell-based treatment is used in selected malignant and non-malignant hematological conditions as part of specialised transplant care.
MBBS, MD (General Medicine), DM (Medical Oncology), Advanced Training in Bone Marrow Transplantation
Chemotherapy, Targeted Therapy, Immunotherapy, Leukemia Treatment, Lymphoma Treatment, Multiple Myeloma Treatment, Kidney Cancer Treatment, Prostate Cancer Treatment, Lung Cancer Treatment, Bone Cancer Treatment, Colorectal Cancer Treatment, Genitourinary Cancer Treatment, Breast Cancer Treatment, Head and Neck Cancer Treatment, Autologous Bone Marrow Transplantation, Allogeneic Bone Marrow Transplantation, Haploidentical Bone Marrow Transplantation, Stem Cell Therapy
Genuine patient experiences and treatment feedback.
Quick answers to common questions about Dr. Radheshyam Naik
Dr. Radheshyam Naik currently practises at HCG Cancer Hospital, K. R. Road in Bengaluru. He is also associated with Sammprada Hospital in Bengaluru, where he serves in a leadership role in Medical Oncology and Bone Marrow Transplantation.
Yes. HCG states that Dr. Radheshyam Naik has studied more than 50 chemotherapy drugs through national and international clinical trials.
Yes. His documented expertise includes kidney, prostate, lung, bone, colorectal, genitourinary, breast and head and neck cancers.
Yes. Leukemia, lymphoma, multiple myeloma and other hematological malignancies are among Dr. Radheshyam Naik's key areas of expertise.
Yes. Bone marrow transplantation is one of Dr. Radheshyam Naik's major documented areas of expertise, including autologous, allogeneic and haploidentical transplantation.
Contact us for personalized help or to schedule an appointment.